Stay updated on Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial
Sign up to get notified when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.

Latest updates to the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page
- Check6 days agoChange DetectedThe history records a new site revision (v3.6.3) being added and the previous v3.6.2 removed. This represents a small software update to the page rather than changes to trial details or records.SummaryDifference0.0%

- Check13 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, indicating a small system update. No study data or navigation elements appear to be affected.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe record history now adds 'No longer looking for participants' and updates the revision to v3.6.0. This indicates a new version of the study record and that enrollment has ended.SummaryDifference0.2%

- Check34 days agoChange DetectedThe revision label on the page updated from v3.5.4 to v3.5.5. This indicates a minor site maintenance or bug fix update rather than changes to the study records or visible content.SummaryDifference0.0%

- Check41 days agoChange DetectedA new version entry was added on 2026-05-28 with updates to Study Status and Contacts/Locations (version 66 indicated for 2026-05-27); the 2026-02-27 entry was removed.SummaryDifference0.2%

- Check56 days agoChange DetectedThe page's revision history updated to include a new entry labeled v3.5.4 and removed the previous v3.5.3 entry, indicating a backend revision to the documentation/versioning.SummaryDifference0.0%

Stay in the know with updates to Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entrectinib vs Crizotinib in ROS1 NSCLC Clinical Trial page.